These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9114949)

  • 21. Case report of a toxic reaction from a combination of tryptophan and phenelzine.
    Thomas JM; Rubin EH
    Am J Psychiatry; 1984 Feb; 141(2):281-3. PubMed ID: 6691495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
    Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous hypertensive reactions with monoamine oxidase inhibitors.
    Lavin MR; Mendelowitz A; Kronig MH
    Biol Psychiatry; 1993 Aug; 34(3):146-51. PubMed ID: 8399806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of MAOI antidepressants.
    Ravaris CL; Robinson DS; Nies A; Ives JO; Bartlett D
    Am Fam Physician; 1978 Jul; 18(1):105-11. PubMed ID: 665471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
    Fawcett J; Kravitz HM; Zajecka JM; Schaff MR
    J Clin Psychopharmacol; 1991 Apr; 11(2):127-32. PubMed ID: 2056139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient compliance with MAO inhibitor therapy.
    Walker JI; Davidson J; Zung WW
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication.
    Feinberg SS
    J Clin Psychiatry; 2004 Nov; 65(11):1520-4. PubMed ID: 15554766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical overview of monoamine oxidase inhibitors.
    Zisook S
    Psychosomatics; 1985 Mar; 26(3):240-6, 251. PubMed ID: 3887453
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting monoamine oxidase inhibitors.
    Krishnan KR
    J Clin Psychiatry; 2007; 68 Suppl 8():35-41. PubMed ID: 17640156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abuse of monoamine oxidase inhibitors.
    Baumbacher G; Hansen MS
    Am J Drug Alcohol Abuse; 1992; 18(4):399-406. PubMed ID: 1449122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B; Foote B; Walsh BT; Roose SP
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL; Sunderland T; Cohen RM
    Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
    Nierenberg AA; Keck PE
    J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine oxidase inhibitors: safety and efficacy issues.
    Brown CS; Bryant SG
    Drug Intell Clin Pharm; 1988 Mar; 22(3):232-5. PubMed ID: 3284731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.